One-Time iron infusion may speed up mobility recovery in hip fracture patients

NCT ID NCT06898814

Recruiting now Symptom relief Sponsor: Soren Overgaard Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a single intravenous dose of iron (ferric derisomaltose) can improve mobility recovery in elderly patients after hip fracture surgery. Researchers will compare the iron group to a placebo group in 210 participants across three Danish hospitals. The main goal is to see if the treatment helps patients regain their pre-fracture walking ability, reduce fatigue, and improve blood counts.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Ferric Derisomaltose (intravenous iron)
What this could lead to: If it works, this could offer a simple, one-time treatment to help elderly patients regain walking ability faster after hip fracture surgery.
What could go wrong: This is a Phase 4 trial, but the benefit may be modest or not apply to all patients. Risks include allergic reactions to iron, and the study is only in Denmark.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anemia hip fracture

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANEMIA HIP FRACTURE

Contacts and locations

Locations

Department of Orthopaedic Surgery, Odense and Svendborg University Hospital
RECRUITING

Odense C, 5000, Denmark
Department of Orthopedic Surgery and Traumatology, Bispebjerg, Copenhagen University Hospital
ACTIVE_NOT_RECRUITING

Copenhagen NV, 2400, Denmark
Department of Orthopedic Surgery and Traumatology, Herlev, Copenhagen University Hospital
RECRUITING

Herlev, 2730, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.